Physician
Abberbock, Gary
Abberbock, Gary was paid $4.06M by Medicaid between Jan 2018 and Dec 2024, across 44 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoABBERBOCK, GARY
BROOKLYN, NY 11230
BROOKLYN, NY 11230
33aNPI1114931789assigned 07/28/2006
33bProvider typePediatrics Physician
28Total paid$4.06M
24GClaims179,881
24DCodes billed44
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#80 of 1,983
Median peer was paid$17K
This provider vs. median239×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,102 | $476K | |
| 2019 | 24,949 | $514K | |
| 2020 | 31,415 | $694K | |
| 2021 | 30,989 | $675K | |
| 2022 | 28,214 | $682K | |
| 2023 | 25,946 | $610K | |
| 2024incomplete | 16,266 | $404K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 31,108 | 25,172 | $1.48M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 8.2% | 10,136 | 9,977 | $333K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.2% | 3,531 | 3,518 | $253K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.2% | 3,840 | 3,699 | $250K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.1% | 3,509 | 3,214 | $245K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.3% | 3,070 | 3,064 | $216K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.6% | 2,396 | 2,392 | $185K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.0% | 22,722 | 19,661 | $162K |
| 87070 | 3.5% | 22,735 | 19,621 | $143K | |
| 86328 | 2.6% | 4,079 | 2,129 | $107K | |
| 87184 | 2.4% | 22,966 | 19,792 | $98K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.3% | 2,758 | 2,584 | $93K |
32 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 13,543 | $77K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.8% | 1,960 | $73K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 4,415 | $67K |
| 99051 | 1.5% | 4,798 | $63K | |
| 69210 | 1.2% | 1,726 | $50K | |
| 83655 | <1% | 3,005 | $27K | |
| 99381 | <1% | 287 | $24K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 200 | $22K |
| 87428 | <1% | 371 | $20K | |
| 99188 | <1% | 1,765 | $18K | |
| 81002 | <1% | 5,607 | $12K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 145 | $11K |
| 90619 | <1% | 39 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 69 | $5K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 94 | $4K |
| 99173 | <1% | 1,521 | $3K | |
| 99177 | <1% | 882 | $3K | |
| 10060 | <1% | 14 | $913.50 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 34 | $890.98 |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 15 | $726.46 |
| 99460 | <1% | 14 | $514.22 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 61 | $357.54 |
| 96127 | <1% | 81 | $343.76 | |
| 99050 | <1% | 24 | $320.64 | |
| 99441 | <1% | 13 | $173.56 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 12 | $143.04 |
| 36416 | <1% | 5,950 | $126.48 | |
| 86580 | <1% | 12 | $96.84 | |
| 81000 | <1% | 26 | $68.90 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13 | $20.93 |
| 97802 | <1% | 167 | $13.38 | |
| 99000 | 0% | 168 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.